Barrington Research Maintains Outperform on Dentsply Sirona, Maintains $14 Price Target

Benzinga · 1d ago
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and maintains $14 price target.